SCHEMBL7968810

SCHEMBL7968810

Cc1nc(N(CCCO)Cc2ccccc2)c2c([S+](C)[O-])nn(-c3c(Cl)cc(Cl)cc3Cl)c2n1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 11/20 0.39
CCND1 P24385 11/20 0.39
CCNE2 O96020 11/20 0.39
CCNE1 P24864 11/20 0.39
CDK2 P24941 11/20 0.39
CCNB2 O95067 4/20 0.39
CDK1 P06493 4/20 0.39
CCNB1 P14635 4/20 0.39
CCNB3 Q8WWL7 4/20 0.39
TDP1 Q9NUW8 1/20 0.36
CRHR1 P34998 4/20 0.35
CYP3A4 P08684 1/20 0.34
ALOX15 P16050 1/20 0.34
TSHR P16473 1/20 0.34
MAPK1 P28482 1/20 0.34
ALDH1A1 P00352 1/20 0.33
HPGD P15428 1/20 0.33
CNR1 P21554 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7963176 0.88 CRHR1 (0.46) CDK4CCND1CCNE2CCNE1CDK2
SCHEMBL7963257 0.85 CDK4 (0.53) CDK4CCND1CCNE2CCNE1CDK2
SCHEMBL7965770 0.83 CDK4 (0.40) CDK4CCND1CCNE2CCNE1CDK2
Acetic Acid SCHEMBL8113498 0.82 CDK4 (0.52) CDK4CCND1CCNE2CCNE1CDK2
SCHEMBL8123969 0.81 CDK4 (0.53) CDK4CCND1CCNE2CCNE1CDK2
SCHEMBL7964151 0.80 CRHR1 (0.43) CDK4CCND1CCNE2CCNE1CDK2
SCHEMBL7963032 0.79 CDK4 (0.51) CDK4CCND1CCNE2CCNE1CDK2
SCHEMBL7966305 0.79 CCNE2 (0.50) CDK4CCND1CCNE2CCNE1CDK2
SCHEMBL7961637 0.78 CDK4 (0.52) CDK4CCND1CCNE2CCNE1CDK2
SCHEMBL7967627 0.77 CDK4 (0.46) CDK4CCND1CCNE2CCNE1CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6218397-B1 FOR THERAPY OF STRESS-RELATED ILLNESSES, SUCH AS STRESS-INDUCED DEPRESSION, ANXIETY, AND HEADACHE; ABDOMINAL BOWEL SYNDROME; INFLAMMATORY DISEASES; IMMUNE SUPPRESSION; ALZHEIMER'S DISEASE; GASTRONINTESTINAL DISEASES PFIZER INC 2001-04-17 US disclosed
EP-0674642-B1 PYRAZOLOPYRIMIDINES AS CRF ANTAGONISTS PFIZER (US) 2000-08-23 EP disclosed
WO-1994013677-A1 PYRAZOLOPYRIMIDINES AS CRF ANTAGONISTS PFIZER INC. (US) 1994-06-23 WO disclosed